Navigation Links
SUNY Downstate receives grant from research to prevent blindness
Date:1/23/2012

Capping SUNY Downstate Medical Center's growth into a major center for eye research, Research to Prevent Blindness (RPB) has awarded SUNY Downstate a four-year challenge grant of $220,000 to spur the development of advanced research into the causes, treatment, and prevention of blinding diseases. Douglas R. Lazzaro, MD, professor and chair of ophthalmology, is the principal investigator. RPB is the world's leading voluntary organization supporting eye research.

"This award from RPB is a major milestone in the development of an ophthalmology research nucleus at SUNY Downstate," said Dr. Lazzaro. SUNY Downstate is now one of 52 institutions receiving this recognition from RPB, which, since its founding in 1960, has channeled hundreds of millions of dollars to medical institutions throughout the United States. In the last five years, Downstate has attracted $6.2 million in eye research funding from various sources.

Dr. Lazzaro's team includes William J. Brunken, PhD, professor of cell biology and ophthalmology and director of ophthalmic research, who is studying the role of the extracellular matrix in retinal development and disease; and John Danias, MD, PhD, professor of cell biology and ophthalmology, who is elucidating the molecular basis of glaucoma and evaluating potential new treatment strategies.

In addition, another member of the team, Brahim Chaqour, PhD, associate professor of cell biology and ophthalmology at Downstate, has been awarded a National Eye Institute grant for research on neovascularization in the retina. Jacob Aranda, MD, PhD, professor of pediatrics and ophthalmology and director of neonatology, was awarded a major grant from the National Institute of Child Health and Human Development to establish a pediatric pharmacology center focused on research to prevent retinopathy of prematurity.

Dr. Lazzaro and Dr. Brunken have also received an Empire Clinical Research Investigator Program (ECRIP) fellowship grant for development of a posterior corneal prosthesis, in collaboration with the SUNY College of Nanoscale Science and Engineering at the University at Albany. Dr. Lazzaro noted, "That SUNY Downstate has gone from virtually zero funding in eye research to more than six million in five years is a tribute to the dedication of the entire eye team here at Downstate."


'/>"/>
Contact: Ron Najman
ron.najman@downstate.edu
718-270-2696
SUNY Downstate Medical Center
Source:Eurekalert

Related biology news :

1. SUNY Downstate researchers find that memory storage molecule preserves complex memories
2. SUNY Downstate researchers identify possible new targets for treating pain in women
3. Wistar Institute researcher receives New Innovator award from NIH
4. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
5. Kount Receives Patent for Device Fingerprinting
6. American College of Medical Genetics receives $13.5M NIH contract
7. Penn State receives new NASA astrobiology grant
8. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
9. Vidaza receives positve opinion from European CHMP
10. Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award
11. Montana State partnership receives $66.9M for carbon sequestration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: